Aphria Inc, a small cap worth $500M, trading on the Toronto Junior Exchange, went parabolic in 2016. Is this stock a buy at this point?
First, some readers would challenge the idea to own shares of a cannabis company. Aphria is committed to providing pharma-grade medical cannabis and superior patient care. In general, we agree with the principles of moral investing, so we stay away from companies with activities in dubious sectors. However, we are focused on what market signals, and we apply our analysis on every type of stock or asset. In other words, whatever the company’s activities, we are primarily interested in understanding the message of the market.